Our findings on the regulation of blood glucose and plasma insulin levels in SITG-treated T2DM-induced rats underscore the possible neuroprotective effects of SITG against diabetes-induced neuronal degeneration. This evidence concerns the gene INS and type 2 diabetes mellitus.